SYNOPSIS The in-vitro action of the sulphamethoxazole/trimethoprim combination (cotrimoxazole) against coliforms, Proteus spp, and Staphylococcus aureus was re-examined. In nutrient broth the components of cotrimoxazole did not produce bacteriostatic synergy against most sulphonamideresistant and a significant proportion of sulphonamide-sensitive strains. Any bactericidal action appeared to be due to the trimethoprim component. After addition to urine the combination was only bacteriostatic against most coliforms and Proteus spp over six hours. Further clinical trials are needed to determine the circumstances under which cotrimoxazole is superior to either trimethoprim or sulphonamides against some infections, particularly of the urinary tract.
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When a combination of sulphamethoxazole with trimethoprim (cotrimoxazole) was introduced in 1968, its chief advantage was thought to be the antibacterial synergism between the two components (Darrell, Garrod, and Waterworth, 1968) . This synergism was found to produce not only a more effective bacteriostatic effect (bacteriostatic synergy) when the drugs were used together rather than singly, but often a bactericidal activity (Darrell et al, 1968; Bushby, 1969) . However, trimethoprim alone has been found to be as effective as the combination in treating urinary infections in outpatients (Brumfitt and Pursell, 1972) , and has some bactericidal activity in vitro (Darrell et al, 1968) . These findings prompted us to re-examine the activity of sulphamethoxazole and trimethoprim in vitro. We have already reported some results of the bactericidal action over 24 hr (Lewis and Lacey, 1973 ). Here we have extended our observations that in nutrient broth the bacteriostatic synergy is unreliable and we have found that any bactericidal action resulting from the combination seems to be due to the trimethoprim component. Furthermore, cotrimoxazole is rarely bactericidal in urine. We therefore suggest that the advisability of invariably combining the drugs in treatment should be subjected to further clinical evaluation. Combined therapy increases the cost and the danger of toxic effects (Brumfitt and Pursell, 1972 ) and presents problems for the laboratory in sensitivity testing. (1968) . Several cultures were also sampled by spreading 0 025 ml over the surface of nutrient agar plates. These methods of sampling were adopted (a) to dilute out residual drugs, (b) to enable an easy check on the presence of contaminants to be made, and (c) to make our results comparable with those of Darrell et al (1968) . The broths were considered to be free of sulphonamide and trimethoprim inhibitors because some cultures of Staph. aureus were destroyed by as little as 0 4 ,tg trimethoprim/ml or 0 4,ug trimethoprim/ml and 8 ,tg sulphamethoxazole/ml (for example see table IV). Sulphamethoxazole alone was bacteriostatic at levels as low as 8 ,ug/ml. Effective bactericidal action was defined as the reduction in the number of viable bacteria to 100% or less of the inoculum. In cultures that were not completely killed by the drugs, a proportion of the surviving organisms were checked for their identity.
BEHAVIOUR OF ORGANISMS IN HUMAN URINE
Twenty-four-hr collections of midstream urine from a healthy individual were sterilized by filtration and then pooled. Sulphamethoxazole (1 mg/ml) and trimethoprim (50 ,ug/ml) were added to 25 ml aliquots (producing little change in pH) and then bacteria were added to a final density of between about 103 and 104 organisms/ml. The inoculated urine was immediately sampled for viable bacteria (Miles and Misra, 1938) (1968) could be due to differences in strains (the latter tested only four strains for bactericidal effect). Strain differences may also account for the discrepancy between our findings and those of Bushby (1969) , because the only coliform (strain CN 314) that we have found to be reliably destroyed within six hr by cotrimoxazole was obtained from his laboratory.
One advantage claimed for using a mixture of trimethoprim and sulphamethoxazole is in the prevention of resistance of bacteria to both drugs simultaneously. The value of this effect, however, is less than it might appear, because (1) many coliforms, Proteus spp, and staphylococci are already resistant to sulphonamides; (2) trimethoprim-resistant mutants with normal growth properties are difficult to isolate in vitro, even in strains already resistant to sulphonamides except for Strep. faecalis (Lewis and Lacey, 1973) ; (3) trimethoprim resistance has remained relatively uncommon in clinical strains, including those resistant to sulphonamides (Lacey, Gillespie, Bruten, and Lewis, 1972; Lewis and Lacey, 1973) ; (4) if resistance to trimethoprim does become common in coliforms, we expect that it will be mediated by R factors-one such R factor that determines resistance to trimethoprim also confers resistance to sulphonamides and has recently been detected in strains isolated in London (Fleming, Datta, and Gruneberg, 1972 
